Vale W - Search Results

1

Immunosuppressive phenotype of corticotropin-releasing factor transgenic mice is reversed by adrenalectomy.

Boehme SA, Gaur A, Crowe PD, Liu XJ, Tamraz S, Wong T, Pahuja A, Ling N, Vale W, De Souza EB, Conlon PJ. Boehme SA, et al. Among authors: vale w. Cell Immunol. 1997 Mar 15;176(2):103-12. doi: 10.1006/cimm.1997.1080. Cell Immunol. 1997. PMID: 9073382

2

Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated.

Heinrichs SC, Min H, Tamraz S, Carmouché M, Boehme SA, Vale WW. Heinrichs SC, et al. Among authors: vale ww. Psychoneuroendocrinology. 1997 May;22(4):215-24. doi: 10.1016/s0306-4530(97)00030-9. Psychoneuroendocrinology. 1997. PMID: 9226726

3

Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.

Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW. Behan DP, et al. Among authors: vale ww. Front Neuroendocrinol. 1995 Oct;16(4):362-82. doi: 10.1006/frne.1995.1013. Front Neuroendocrinol. 1995. PMID: 8557170 Review.

4

Modulatory actions of corticotropin-releasing factor-binding protein.

Behan DP, De Souza EB, Potter E, Sawchenko P, Lowry PJ, Vale WW. Behan DP, et al. Among authors: vale ww. Ann N Y Acad Sci. 1996 Mar 22;780:81-95. doi: 10.1111/j.1749-6632.1996.tb15113.x. Ann N Y Acad Sci. 1996. PMID: 8602741 Review. No abstract available.

5

125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.

Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB. Grigoriadis DE, et al. Among authors: vale ww. Mol Pharmacol. 1996 Sep;50(3):679-86. Mol Pharmacol. 1996. PMID: 8794910

6

Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal.

Heinrichs SC, Lapsansky J, Behan DP, Chan RK, Sawchenko PE, Lorang M, Ling N, Vale WW, De Souza EB. Heinrichs SC, et al. Among authors: vale ww. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15475-80. doi: 10.1073/pnas.93.26.15475. Proc Natl Acad Sci U S A. 1996. PMID: 8986836 Free PMC article.

7

Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system.

Poliak S, Mor F, Conlon P, Wong T, Ling N, Rivier J, Vale W, Steinman L. Poliak S, et al. Among authors: vale w. J Immunol. 1997 Jun 15;158(12):5751-6. J Immunol. 1997. PMID: 9190925

8

Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.

Hoare SR, Sullivan SK, Schwarz DA, Ling N, Vale WW, Crowe PD, Grigoriadis DE. Hoare SR, et al. Among authors: vale ww. Biochemistry. 2004 Apr 6;43(13):3996-4011. doi: 10.1021/bi036110a. Biochemistry. 2004. PMID: 15049707

9

Differential regulation of corticotropin-releasing factor receptors in anterior and intermediate lobes of pituitary and in brain following adrenalectomy in rats.

De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ. De Souza EB, et al. Among authors: vale ww. Neurosci Lett. 1985 May 14;56(2):121-8. doi: 10.1016/0304-3940(85)90117-x. Neurosci Lett. 1985. PMID: 2989738

10

Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.

De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW. De Souza EB, et al. Among authors: vale ww. Nature. 1986 Feb 13-19;319(6054):593-5. doi: 10.1038/319593a0. Nature. 1986. PMID: 3003585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

921 results

Search Page